Talazoparib in Advanced Breast Cancer Patients With Homologous Recombinant Deficiency

NCT04892693 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Talazoparib Oral Capsule

Sponsor

Seoul National University Hospital